rdf:type |
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0009566,
umls-concept:C0015967,
umls-concept:C0021311,
umls-concept:C0034866,
umls-concept:C0043227,
umls-concept:C0087111,
umls-concept:C1136254,
umls-concept:C1257890,
umls-concept:C1328050,
umls-concept:C1442989,
umls-concept:C1555762,
umls-concept:C1556085,
umls-concept:C1831743,
umls-concept:C1948041
|
pubmed:dateCreated |
1999-7-27
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0012-0472
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
9
|
pubmed:volume |
124 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S9-13
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
|
pubmed:year |
1999
|
pubmed:articleTitle |
[Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology].
|
pubmed:affiliation |
Robert-Rössle-Klinik am Max-Delbrück-Centrum f aur Molekulare Medizin, Universitätsklinikum Charité, Medizinische Fakultät, Humboldt-Universität Berlin-Buch. maschmeyer@rrk-berlin.de
|
pubmed:publicationType |
Journal Article,
Guideline,
Practice Guideline
|